During the past 12 months, Dr. Martens's average EBITDA Per Share Growth Rate was 15.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -17.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -8.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dr. Martens was 50.10% per year. The lowest was -24.60% per year. And the median was 11.40% per year.
Dr. Martens (OTCPK:DOCMF) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Dr. Martens 5-Year EBITDA Growth Rate Related Terms
DOCMF vs NKE, DECK, ONON: 5-Year EBITDA Growth Rate Comparison
For the Footwear & Accessories subindustry, Dr. Martens's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens 5-Year EBITDA Growth Rate vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Dr. Martens's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of -8.70% mean?
Dr. Martens (DOCMF) has a 5-Year EBITDA Growth Rate of -8.70% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' 5-Year EBITDA Growth Rate too high?
Dr. Martens' current 5-Year EBITDA Growth Rate is -8.70%. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' 5-Year EBITDA Growth Rate compare to NKE and DECK?
Dr. Martens' 5-Year EBITDA Growth Rate of -8.70% can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Manufacturing - Apparel & Accessories company?
A good 5-Year EBITDA Growth Rate depends on the Manufacturing - Apparel & Accessories industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Dr. Martens and its competitors. Dr. Martens's current 5-Year EBITDA Growth Rate is -8.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.97 — trading right at its estimated fair value. The current 5-Year EBITDA Growth Rate is -8.70%. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current 5-Year EBITDA Growth Rate is -8.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $0.97 is trading 0% below its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DOCMF:
5-Year EBITDA Growth Rate: -8.70%
GF Value™: $0.97 vs. price of $0.97 (0% below fair value)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 